FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2428312615> ?p ?o ?g. }

• W2428312615 endingPage "83" @default.
• W2428312615 startingPage "22477" @default.
• W2428312615 abstract "Nonalcoholic steatohepatitis (NASH) is currently one of the primary liver diseases. Recent studies have shown a clinical relation between NASH and atherosclerosis. There is much interest in these two diseases because they are both associated with great morbidity and mortality. Inflammation and the overexpression of COX-2 participate in the pathophysiology of the two diseases, and therefore simultaneous treatment is feasible. The role of the four NSAIDs, meclofenamate, mefenamate, flufenamate, and aspirin, was analyzed in a mouse model of NASH, as well as preclinical atherosclerosis induced by a high-fat diet (HFD). Six mouse groups were formed. Five of the groups were fed a high-fat diet for 6 months and one group was fed a standard diet, acting as the normality reference. Of the five groups fed a high-fat diet, four received a NSAID, each of them identified by the specific drug administered. One group received no treatment. Serum markers (cholesterol, triglycerides, ALT, and AST) and histologic changes in the aorta and liver were analyzed for the study. Aspirin significantly reduced the hepaticsteatosis. All the drugs significantly reduced the hepatic inflammatory infiltrate. In relation to atherosclerosis, there were significant reductions in all the study variables with the use of aspirin and flufenamate. The four medications were able to stop steatosis from progressing into steatohepatitis by reducing inflammation. However, aspirin was the most beneficial, simultaneously reducing steatosis, atherosclerosis, and serum cholesterol levels." @default.
• W2428312615 created "2016-06-24" @default.
• W2428312615 creator A5006294627 @default.
• W2428312615 creator A5013412871 @default.
• W2428312615 creator A5018926727 @default.
• W2428312615 creator A5020368412 @default.
• W2428312615 creator A5022866681 @default.
• W2428312615 creator A5049565721 @default.
• W2428312615 creator A5058185308 @default.
• W2428312615 creator A5063420040 @default.
• W2428312615 creator A5068666686 @default.
• W2428312615 creator A5070889297 @default.
• W2428312615 creator A5073990686 @default.
• W2428312615 creator A5077523242 @default.
• W2428312615 creator A5079015348 @default.
• W2428312615 creator A5082436256 @default.
• W2428312615 creator A5088434744 @default.
• W2428312615 date "2015-01-01" @default.
• W2428312615 modified "2023-10-18" @default.
• W2428312615 title "Preclinical analysis of nonsteroidal anti-inflammatory drug usefulness for the simultaneous prevention of steatohepatitis, atherosclerosis and hyperlipidemia." @default.
• W2428312615 cites W167112677 @default.
• W2428312615 cites W1964902219 @default.
• W2428312615 cites W2012616752 @default.
• W2428312615 cites W2024175 @default.
• W2428312615 cites W2028770303 @default.
• W2428312615 cites W2044067781 @default.
• W2428312615 cites W2058446823 @default.
• W2428312615 cites W2069415735 @default.
• W2428312615 cites W2069439847 @default.
• W2428312615 cites W2088600483 @default.
• W2428312615 cites W2106838509 @default.
• W2428312615 cites W2113184924 @default.
• W2428312615 cites W2129177530 @default.
• W2428312615 cites W2140004486 @default.
• W2428312615 cites W2140873713 @default.
• W2428312615 cites W2149083834 @default.
• W2428312615 cites W2149307753 @default.
• W2428312615 cites W2152505303 @default.
• W2428312615 cites W2416866036 @default.
• W2428312615 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4730016" @default.
• W2428312615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26885230" @default.
• W2428312615 hasPublicationYear "2015" @default.
• W2428312615 type Work @default.
• W2428312615 sameAs 2428312615 @default.
• W2428312615 citedByCount "9" @default.
• W2428312615 countsByYear W24283126152017 @default.
• W2428312615 countsByYear W24283126152018 @default.
• W2428312615 countsByYear W24283126152022 @default.
• W2428312615 countsByYear W24283126152023 @default.
• W2428312615 crossrefType "journal-article" @default.
• W2428312615 hasAuthorship W2428312615A5006294627 @default.
• W2428312615 hasAuthorship W2428312615A5013412871 @default.
• W2428312615 hasAuthorship W2428312615A5018926727 @default.
• W2428312615 hasAuthorship W2428312615A5020368412 @default.
• W2428312615 hasAuthorship W2428312615A5022866681 @default.
• W2428312615 hasAuthorship W2428312615A5049565721 @default.
• W2428312615 hasAuthorship W2428312615A5058185308 @default.
• W2428312615 hasAuthorship W2428312615A5063420040 @default.
• W2428312615 hasAuthorship W2428312615A5068666686 @default.
• W2428312615 hasAuthorship W2428312615A5070889297 @default.
• W2428312615 hasAuthorship W2428312615A5073990686 @default.
• W2428312615 hasAuthorship W2428312615A5077523242 @default.
• W2428312615 hasAuthorship W2428312615A5079015348 @default.
• W2428312615 hasAuthorship W2428312615A5082436256 @default.
• W2428312615 hasAuthorship W2428312615A5088434744 @default.
• W2428312615 hasConcept C126322002 @default.
• W2428312615 hasConcept C134018914 @default.
• W2428312615 hasConcept C2776175330 @default.
• W2428312615 hasConcept C2776914184 @default.
• W2428312615 hasConcept C2777628954 @default.
• W2428312615 hasConcept C2778772119 @default.
• W2428312615 hasConcept C2779091943 @default.
• W2428312615 hasConcept C2779134260 @default.
• W2428312615 hasConcept C2779478299 @default.
• W2428312615 hasConcept C2780035454 @default.
• W2428312615 hasConcept C555293320 @default.
• W2428312615 hasConcept C71924100 @default.
• W2428312615 hasConcept C90924648 @default.
• W2428312615 hasConcept C98274493 @default.
• W2428312615 hasConceptScore W2428312615C126322002 @default.
• W2428312615 hasConceptScore W2428312615C134018914 @default.
• W2428312615 hasConceptScore W2428312615C2776175330 @default.
• W2428312615 hasConceptScore W2428312615C2776914184 @default.
• W2428312615 hasConceptScore W2428312615C2777628954 @default.
• W2428312615 hasConceptScore W2428312615C2778772119 @default.
• W2428312615 hasConceptScore W2428312615C2779091943 @default.
• W2428312615 hasConceptScore W2428312615C2779134260 @default.
• W2428312615 hasConceptScore W2428312615C2779478299 @default.
• W2428312615 hasConceptScore W2428312615C2780035454 @default.
• W2428312615 hasConceptScore W2428312615C555293320 @default.
• W2428312615 hasConceptScore W2428312615C71924100 @default.
• W2428312615 hasConceptScore W2428312615C90924648 @default.
• W2428312615 hasConceptScore W2428312615C98274493 @default.
• W2428312615 hasIssue "12" @default.
• W2428312615 hasLocation W24283126151 @default.
• W2428312615 hasOpenAccess W2428312615 @default.
• W2428312615 hasPrimaryLocation W24283126151 @default.
• W2428312615 hasRelatedWork W1965567565 @default.

• next